Genomic Health reports positive results from Oncotype DX clinical study in women with

[News]

Genomic Health, Inc. today announced positive results from the second large clinical validation study of Oncotype DX in patients with a pre-invasive form of breast cancer known as DCIS (ductal carcinoma in situ).

More... (http://www.news-medical.net/news/20141213/Genomic-Health-reports-positive-results-from-Oncotype-DX-clinical-study-in-women-with-DCIS.aspx)